C. difficile infection tied to chemo delay, hospitalization in paediatric oncology, HSCT patients
Clostridioides difficile infection (CDI) in paediatric oncology and haematopoietic stem cell transplant (HSCT) patients is associated with delay in chemotherapy and hospitalization, but not with morbidity or mortality since patients have neither attributable intensive care unit admission nor death, according to a recent study. In addition, H2-antagonists are independently predictive of CDI recurrence.
C. difficile infection tied to chemo delay, hospitalization in paediatric oncology, HSCT patients
12 Jul 2021
